Our Company
Presentation
Management Team
Board of directors
Scientific Advisory Board
Contact
Products
Tedopi®
OSE-279
OSE-127/Lusvertikimab
FR104/VEL-101
BI 770371
ABBV-230
CLEC-1
Research & Development
Scientific publications
Investors
Press Releases
Regulated information
Financial documents
General Shareholders’ meetings
Partnerships
Pharma partnerships
Clinical partnerships
Academic and public Partnerships
News
Agenda
Press Releases
Contact
en
fr
Projects Archives
February 2022
Investor Access Event Paris
February 2022
‘Midcap Event’ Paris
February 2022
Investor Access Event Paris
February 2022
‘Smallcap Event’ Paris
February 2022
Maxim Group 2022 Virtual Growth Conference
February 2022
European ‘Midcap Event’
December 2021
Immuno-Oncology R&D Day
November 2021
H.C. Wainwright BIOCONNECT Virtual Conference
November 2021
LifeSci Partners Corporate Access Event
November 2021
European Midcap Event
Précédent
1
2
3
4
5
Suivant